APO Research
Talk to an analyst

APO RESEARCH · REPORT

4 Factor Pro-thrombin Complex Concentrate

4 Factor Pro-thrombin Complex Concentrate refers to medicinal, supplement or research preparations identified by the named composition or biological target.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Identity, formulation, stock form, controls and documented use define the preparation; market categories and images do not establish approval, dosing or patient suitability.

What turns activity into demand

Distinguish equipment procurement, recurring materials and any related service within the selected study. Research use, educational use and clinical use have different acceptance requirements and should not be treated as one demand measure.

The commercial boundary

Separate research materials, devices and services within the selected edition. Approvals, labelled use and clinical acceptance need their own evidence; no medical suitability follows from this illustration.

Which supplied scope and interfaces define 4 Factor Pro-thrombin Complex Concentrate?

Identity, formulation, stock form, controls and documented use define the preparation; market categories and images do not establish approval, dosing or patient suitability.

Technical reading

Selected research

Market Outlook & Growth Opportunities

Global 4 Factor Pro-thrombin Complex Concentrate Market Outlook and Growth Opportunities 2026

21 December 2025191 pages

Choose your research edition.

Industry Research4 Factor Pro-thrombin Complex Concentrate Industry Research Report 2026109 pages · $2,950 USDIndustry Growth & TrendsGlobal 4 Factor Pro-thrombin Complex Concentrate Industry Growth and Trends Forecast to 203274 pages · $3,450 USDMarket StructureGlobal 4 Factor Pro-thrombin Complex Concentrate Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032174 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal 4 Factor Pro-thrombin Complex Concentrate Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal 4 Factor Pro-thrombin Complex Concentrate Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global 4 Factor Pro-thrombin Complex Concentrate market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for 4 Factor Pro-thrombin Complex Concentrate is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for 4 Factor Pro-thrombin Complex Concentrate is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for 4 Factor Pro-thrombin Complex Concentrate is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the 4 Factor Pro-thrombin Complex Concentrate market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the 4 Factor Pro-thrombin Complex Concentrate market include Takeda, Prothya Biosolutions, Octapharma and CSL Behring, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global 4 Factor Pro-thrombin Complex Concentrate market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of 4 Factor Pro-thrombin Complex Concentrate and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents 4 Factor Pro-thrombin Complex Concentrate sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the 4 Factor Pro-thrombin Complex Concentrate market size, projected growth trends, production technologies, key applications, and end-use industries.

4 Factor Pro-thrombin Complex Concentrate Segment by Company

Takeda

Prothya Biosolutions

Octapharma

CSL Behring

4 Factor Pro-thrombin Complex Concentrate Segment by Type

Prothromplex

Octaplex

Cofact

Beriplex

Other

4 Factor Pro-thrombin Complex Concentrate Segment by Application

Hemophilia B

Acquired Coagulation Factor Deficiency

4 Factor Pro-thrombin Complex Concentrate Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global 4 Factor Pro-thrombin Complex Concentrate status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions 4 Factor Pro-thrombin Complex Concentrate market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify 4 Factor Pro-thrombin Complex Concentrate significant trends, drivers, influence factors in global and regions.

6. To analyze 4 Factor Pro-thrombin Complex Concentrate competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global 4 Factor Pro-thrombin Complex Concentrate market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of 4 Factor Pro-thrombin Complex Concentrate and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of 4 Factor Pro-thrombin Complex Concentrate.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the 4 Factor Pro-thrombin Complex Concentrate market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global 4 Factor Pro-thrombin Complex Concentrate industry.

Chapter 3: Detailed analysis of 4 Factor Pro-thrombin Complex Concentrate manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of 4 Factor Pro-thrombin Complex Concentrate in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of 4 Factor Pro-thrombin Complex Concentrate in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. 4 Factor Pro-thrombin Complex Concentrate Industry Trends Table 2. 4 Factor Pro-thrombin Complex Concentrate Industry Drivers Table 3. 4 Factor Pro-thrombin Complex Concentrate Industry Opportunities and Challenges Table 4. 4 Factor Pro-thrombin Complex Concentrate Industry Restraints Table 5. Global 4 Factor Pro-thrombin Complex Concentrate Revenue by Company (US$ Million) & (2021-2026) Table 6. Global 4 Factor Pro-thrombin Complex Concentrate Revenue Share by Company (2021-2026) Table 7. Global 4 Factor Pro-thrombin Complex Concentrate Sales Volume by Company (k units) & (2021-2026) Table 8. Global 4 Factor Pro-thrombin Complex Concentrate Sales Volume Share by Company (2021-2026) Table 9. Global 4 Factor Pro-thrombin Complex Concentrate Average Price (US$/unit) of Company (2021-2026) Table 10. Global 4 Factor Pro-thrombin Complex Concentrate Company Ranking, (2024-2026) & (USD Million) Table 11. Global 4 Factor Pro-thrombin Complex Concentrate Key Company Manufacturing Base & Headquarters Table 12. Global 4 Factor Pro-thrombin Complex Concentrate Company, Product Type & Application Table 13. Global 4 Factor Pro-thrombin Complex Concentrate Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global 4 Factor Pro-thrombin Complex Concentrate by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Prothromplex Table 18. Significant Companies of Octaplex Table 19. Significant Companies of Cofact Table 20. Significant Companies of Beriplex Table 21. Significant Companies of Other Table 22. Global 4 Factor Pro-thrombin Complex Concentrate Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 23. Global 4 Factor Pro-thrombin Complex Concentrate Sales Volume by Type (2021-2026) & (k units) Table 24. Global 4 Factor Pro-thrombin Complex Concentrate Sales Volume by Type (2027-2032) & (k units) Table 25. Global 4 Factor Pro-thrombin Complex Concentrate Sales Volume Share by Type (2021-2026) Table 26. Global 4 Factor Pro-thrombin Complex Concentrate Sales Volume Share by Type (2027-2032) Table 27. Global 4 Factor Pro-thrombin Complex Concentrate Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global 4 Factor Pro-thrombin Complex Concentrate Sales Value by Type (2021-2026) & (US$ Million) Table 29. Global 4 Factor Pro-thrombin Complex Concentrate Sales Value by Type (2027-2032) & (US$ Million) Table 30. Global 4 Factor Pro-thrombin Complex Concentrate Sales Value Share by Type (2021-2026) Table 31. Global 4 Factor Pro-thrombin Complex Concentrate Sales Value Share by Type (2027-2032) Table 32. Significant Companies of Hemophilia B Table 33. Significant Companies of Acquired Coagulation Factor Deficiency Table 34. Global 4 Factor Pro-thrombin Complex Concentrate Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 35. Global 4 Factor Pro-thrombin Complex Concentrate Sales Volume by Application (2021-2026) & (k units) Table 36. Global 4 Factor Pro-thrombin Complex Concentrate Sales Volume by Application (2027-2032) & (k units) Table 37. Global 4 Factor Pro-thrombin Complex Concentrate Sales Volume Share by Application (2021-2026) Table 38. Global 4 Factor Pro-thrombin Complex Concentrate Sales Volume Share by Application (2027-2032) Table 39. Global 4 Factor Pro-thrombin Complex Concentrate Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global 4 Factor Pro-thrombin Complex Concentrate Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global 4 Factor Pro-thrombin Complex Concentrate Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global 4 Factor Pro-thrombin Complex Concentrate Sales Value Share by Application (2021-2026) Table 43. Global 4 Factor Pro-thrombin Complex Concentrate Sales Value Share by Application (2027-2032) Table 44. Global 4 Factor Pro-thrombin Complex Concentrate Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 45. Global 4 Factor Pro-thrombin Complex Concentrate Sales by Region (2021-2026) & (k units) Table 46. Global 4 Factor Pro-thrombin Complex Concentrate Sales Market Share by Region (2021-2026) Table 47. Global 4 Factor Pro-thrombin Complex Concentrate Sales by Region (2027-2032) & (k units) Table 48. Global 4 Factor Pro-thrombin Complex Concentrate Sales Market Share by Region (2027-2032) Table 49. Global 4 Factor Pro-thrombin Complex Concentrate Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global 4 Factor Pro-thrombin Complex Concentrate Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global 4 Factor Pro-thrombin Complex Concentrate Sales Value Share by Region (2021-2026) Table 52. Global 4 Factor Pro-thrombin Complex Concentrate Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global 4 Factor Pro-thrombin Complex Concentrate Sales Value Share by Region (2027-2032) Table 54. Global 4 Factor Pro-thrombin Complex Concentrate Market Average Price (US$/unit) by Region (2021-2026) Table 55. Global 4 Factor Pro-thrombin Complex Concentrate Market Average Price (US$/unit) by Region (2027-2032) Table 56. Global 4 Factor Pro-thrombin Complex Concentrate Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 57. Global 4 Factor Pro-thrombin Complex Concentrate Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global 4 Factor Pro-thrombin Complex Concentrate Sales by Country (2021-2026) & (k units) Table 59. Global 4 Factor Pro-thrombin Complex Concentrate Sales Market Share by Country (2021-2026) Table 60. Global 4 Factor Pro-thrombin Complex Concentrate Sales by Country (2027-2032) & (k units) Table 61. Global 4 Factor Pro-thrombin Complex Concentrate Sales Market Share by Country (2027-2032) Table 62. Global 4 Factor Pro-thrombin Complex Concentrate Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global 4 Factor Pro-thrombin Complex Concentrate Sales Value Market Share by Country (2021-2026) Table 64. Global 4 Factor Pro-thrombin Complex Concentrate Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global 4 Factor Pro-thrombin Complex Concentrate Sales Value Market Share by Country (2027-2032) Table 66. Takeda Company Information Table 67. Takeda Business Overview Table 68. Takeda 4 Factor Pro-thrombin Complex Concentrate Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 69. Takeda 4 Factor Pro-thrombin Complex Concentrate Product Portfolio Table 70. Takeda Recent Development Table 71. Prothya Biosolutions Company Information Table 72. Prothya Biosolutions Business Overview Table 73. Prothya Biosolutions 4 Factor Pro-thrombin Complex Concentrate Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Prothya Biosolutions 4 Factor Pro-thrombin Complex Concentrate Product Portfolio Table 75. Prothya Biosolutions Recent Development Table 76. Octapharma Company Information Table 77. Octapharma Business Overview Table 78. Octapharma 4 Factor Pro-thrombin Complex Concentrate Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Octapharma 4 Factor Pro-thrombin Complex Concentrate Product Portfolio Table 80. Octapharma Recent Development Table 81. CSL Behring Company Information Table 82. CSL Behring Business Overview Table 83. CSL Behring 4 Factor Pro-thrombin Complex Concentrate Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. CSL Behring 4 Factor Pro-thrombin Complex Concentrate Product Portfolio Table 85. CSL Behring Recent Development Table 86. Key Raw Materials Table 87. Raw Materials Key Suppliers Table 88. 4 Factor Pro-thrombin Complex Concentrate Distributors List Table 89. 4 Factor Pro-thrombin Complex Concentrate Customers List Table 90. Research Programs/Design for This Report Table 91. Authors List of This Report Table 92. Secondary Sources Table 93. Primary Sources List of Figures Figure 1. 4 Factor Pro-thrombin Complex Concentrate Product Image Figure 2. Global 4 Factor Pro-thrombin Complex Concentrate Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global 4 Factor Pro-thrombin Complex Concentrate Sales Value (2021-2032) & (US$ Million) Figure 4. Global 4 Factor Pro-thrombin Complex Concentrate Sales (2021-2032) & (k units) Figure 5. Global 4 Factor Pro-thrombin Complex Concentrate Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global 4 Factor Pro-thrombin Complex Concentrate Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Prothromplex Image Figure 10. Octaplex Image Figure 11. Cofact Image Figure 12. Beriplex Image Figure 13. Other Image Figure 14. Global 4 Factor Pro-thrombin Complex Concentrate Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 15. Global 4 Factor Pro-thrombin Complex Concentrate Sales Volume Share 2021 VS 2025 VS 2032 Figure 16. Global 4 Factor Pro-thrombin Complex Concentrate Sales Volume Share by Type (2021-2032) Figure 17. Global 4 Factor Pro-thrombin Complex Concentrate Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global 4 Factor Pro-thrombin Complex Concentrate Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global 4 Factor Pro-thrombin Complex Concentrate Sales Value Share by Type (2021-2032) Figure 20. Hemophilia B Image Figure 21. Acquired Coagulation Factor Deficiency Image Figure 22. Global 4 Factor Pro-thrombin Complex Concentrate Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 23. Global 4 Factor Pro-thrombin Complex Concentrate Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global 4 Factor Pro-thrombin Complex Concentrate Sales Volume Share by Application (2021-2032) Figure 25. Global 4 Factor Pro-thrombin Complex Concentrate Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global 4 Factor Pro-thrombin Complex Concentrate Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global 4 Factor Pro-thrombin Complex Concentrate Sales Value Share by Application (2021-2032) Figure 28. Global 4 Factor Pro-thrombin Complex Concentrate Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 29. Global 4 Factor Pro-thrombin Complex Concentrate Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global 4 Factor Pro-thrombin Complex Concentrate Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global 4 Factor Pro-thrombin Complex Concentrate Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America 4 Factor Pro-thrombin Complex Concentrate Sales Value (2021-2032) & (US$ Million) Figure 33. North America 4 Factor Pro-thrombin Complex Concentrate Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe 4 Factor Pro-thrombin Complex Concentrate Sales Value (2021-2032) & (US$ Million) Figure 35. Europe 4 Factor Pro-thrombin Complex Concentrate Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific 4 Factor Pro-thrombin Complex Concentrate Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific 4 Factor Pro-thrombin Complex Concentrate Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America 4 Factor Pro-thrombin Complex Concentrate Sales Value (2021-2032) & (US$ Million) Figure 39. South America 4 Factor Pro-thrombin Complex Concentrate Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa 4 Factor Pro-thrombin Complex Concentrate Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa 4 Factor Pro-thrombin Complex Concentrate Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA 4 Factor Pro-thrombin Complex Concentrate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA 4 Factor Pro-thrombin Complex Concentrate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA 4 Factor Pro-thrombin Complex Concentrate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada 4 Factor Pro-thrombin Complex Concentrate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada 4 Factor Pro-thrombin Complex Concentrate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada 4 Factor Pro-thrombin Complex Concentrate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico 4 Factor Pro-thrombin Complex Concentrate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico 4 Factor Pro-thrombin Complex Concentrate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico 4 Factor Pro-thrombin Complex Concentrate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany 4 Factor Pro-thrombin Complex Concentrate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany 4 Factor Pro-thrombin Complex Concentrate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany 4 Factor Pro-thrombin Complex Concentrate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France 4 Factor Pro-thrombin Complex Concentrate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France 4 Factor Pro-thrombin Complex Concentrate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France 4 Factor Pro-thrombin Complex Concentrate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. 4 Factor Pro-thrombin Complex Concentrate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. 4 Factor Pro-thrombin Complex Concentrate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. 4 Factor Pro-thrombin Complex Concentrate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy 4 Factor Pro-thrombin Complex Concentrate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy 4 Factor Pro-thrombin Complex Concentrate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy 4 Factor Pro-thrombin Complex Concentrate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain 4 Factor Pro-thrombin Complex Concentrate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain 4 Factor Pro-thrombin Complex Concentrate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain 4 Factor Pro-thrombin Complex Concentrate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia 4 Factor Pro-thrombin Complex Concentrate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia 4 Factor Pro-thrombin Complex Concentrate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia 4 Factor Pro-thrombin Complex Concentrate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands 4 Factor Pro-thrombin Complex Concentrate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands 4 Factor Pro-thrombin Complex Concentrate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands 4 Factor Pro-thrombin Complex Concentrate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries 4 Factor Pro-thrombin Complex Concentrate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries 4 Factor Pro-thrombin Complex Concentrate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries 4 Factor Pro-thrombin Complex Concentrate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China 4 Factor Pro-thrombin Complex Concentrate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China 4 Factor Pro-thrombin Complex Concentrate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China 4 Factor Pro-thrombin Complex Concentrate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan 4 Factor Pro-thrombin Complex Concentrate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan 4 Factor Pro-thrombin Complex Concentrate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan 4 Factor Pro-thrombin Complex Concentrate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea 4 Factor Pro-thrombin Complex Concentrate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea 4 Factor Pro-thrombin Complex Concentrate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea 4 Factor Pro-thrombin Complex Concentrate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India 4 Factor Pro-thrombin Complex Concentrate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India 4 Factor Pro-thrombin Complex Concentrate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India 4 Factor Pro-thrombin Complex Concentrate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia 4 Factor Pro-thrombin Complex Concentrate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia 4 Factor Pro-thrombin Complex Concentrate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia 4 Factor Pro-thrombin Complex Concentrate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia 4 Factor Pro-thrombin Complex Concentrate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia 4 Factor Pro-thrombin Complex Concentrate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia 4 Factor Pro-thrombin Complex Concentrate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil 4 Factor Pro-thrombin Complex Concentrate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil 4 Factor Pro-thrombin Complex Concentrate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil 4 Factor Pro-thrombin Complex Concentrate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina 4 Factor Pro-thrombin Complex Concentrate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina 4 Factor Pro-thrombin Complex Concentrate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina 4 Factor Pro-thrombin Complex Concentrate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile 4 Factor Pro-thrombin Complex Concentrate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile 4 Factor Pro-thrombin Complex Concentrate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile 4 Factor Pro-thrombin Complex Concentrate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia 4 Factor Pro-thrombin Complex Concentrate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia 4 Factor Pro-thrombin Complex Concentrate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia 4 Factor Pro-thrombin Complex Concentrate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru 4 Factor Pro-thrombin Complex Concentrate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru 4 Factor Pro-thrombin Complex Concentrate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru 4 Factor Pro-thrombin Complex Concentrate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia 4 Factor Pro-thrombin Complex Concentrate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia 4 Factor Pro-thrombin Complex Concentrate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia 4 Factor Pro-thrombin Complex Concentrate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel 4 Factor Pro-thrombin Complex Concentrate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia 4 Factor Pro-thrombin Complex Concentrate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia 4 Factor Pro-thrombin Complex Concentrate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE 4 Factor Pro-thrombin Complex Concentrate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE 4 Factor Pro-thrombin Complex Concentrate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE 4 Factor Pro-thrombin Complex Concentrate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey 4 Factor Pro-thrombin Complex Concentrate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey 4 Factor Pro-thrombin Complex Concentrate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey 4 Factor Pro-thrombin Complex Concentrate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran 4 Factor Pro-thrombin Complex Concentrate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran 4 Factor Pro-thrombin Complex Concentrate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran 4 Factor Pro-thrombin Complex Concentrate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt 4 Factor Pro-thrombin Complex Concentrate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt 4 Factor Pro-thrombin Complex Concentrate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt 4 Factor Pro-thrombin Complex Concentrate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. 4 Factor Pro-thrombin Complex Concentrate Value Chain Figure 127. Manufacturing Cost Structure Figure 128. 4 Factor Pro-thrombin Complex Concentrate Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • Prothromplex
  • Octaplex
  • Cofact
  • Beriplex
  • Other
Applications
  • Hemophilia B
  • Acquired Coagulation Factor Deficiency
Companies covered
  • Takeda
  • Prothya Biosolutions
  • Octapharma
  • CSL Behring

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global 4 Factor Pro-thrombin Complex Concentrate Sales Value (2021-2032)
  4. 1.2.2 Global 4 Factor Pro-thrombin Complex Concentrate Sales Volume (2021-2032)
  5. 1.2.3 Global 4 Factor Pro-thrombin Complex Concentrate Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 4 Factor Pro-thrombin Complex Concentrate Market Dynamics
  1. 2.1 4 Factor Pro-thrombin Complex Concentrate Industry Trends
  2. 2.2 4 Factor Pro-thrombin Complex Concentrate Industry Drivers
  3. 2.3 4 Factor Pro-thrombin Complex Concentrate Industry Opportunities and Challenges
  4. 2.4 4 Factor Pro-thrombin Complex Concentrate Industry Restraints
3 4 Factor Pro-thrombin Complex Concentrate Market by Company
  1. 3.1 Global 4 Factor Pro-thrombin Complex Concentrate Company Revenue Ranking in 2025
  2. 3.2 Global 4 Factor Pro-thrombin Complex Concentrate Revenue by Company (2021-2026)
  3. 3.3 Global 4 Factor Pro-thrombin Complex Concentrate Sales Volume by Company (2021-2026)
  4. 3.4 Global 4 Factor Pro-thrombin Complex Concentrate Average Price by Company (2021-2026)
  5. 3.5 Global 4 Factor Pro-thrombin Complex Concentrate Company Ranking (2024-2026)
  6. 3.6 Global 4 Factor Pro-thrombin Complex Concentrate Company Manufacturing Base and Headquarters
  7. 3.7 Global 4 Factor Pro-thrombin Complex Concentrate Company Product Type and Application
  8. 3.8 Global 4 Factor Pro-thrombin Complex Concentrate Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global 4 Factor Pro-thrombin Complex Concentrate Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 4 Factor Pro-thrombin Complex Concentrate Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 4 Factor Pro-thrombin Complex Concentrate Market by Type
  1. 4.1 4 Factor Pro-thrombin Complex Concentrate Type Introduction
  2. 4.1.1 Prothromplex
  3. 4.1.2 Octaplex
  4. 4.1.3 Cofact
  5. 4.1.4 Beriplex
  6. 4.1.5 Other
  7. 4.2 Global 4 Factor Pro-thrombin Complex Concentrate Sales Volume by Type
  8. 4.2.1 Global 4 Factor Pro-thrombin Complex Concentrate Sales Volume by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global 4 Factor Pro-thrombin Complex Concentrate Sales Volume by Type (2021-2032)
  10. 4.2.3 Global 4 Factor Pro-thrombin Complex Concentrate Sales Volume Share by Type (2021-2032)
  11. 4.3 Global 4 Factor Pro-thrombin Complex Concentrate Sales Value by Type
  12. 4.3.1 Global 4 Factor Pro-thrombin Complex Concentrate Sales Value by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global 4 Factor Pro-thrombin Complex Concentrate Sales Value by Type (2021-2032)
  14. 4.3.3 Global 4 Factor Pro-thrombin Complex Concentrate Sales Value Share by Type (2021-2032)
5 4 Factor Pro-thrombin Complex Concentrate Market by Application
  1. 5.1 4 Factor Pro-thrombin Complex Concentrate Application Introduction
  2. 5.1.1 Hemophilia B
  3. 5.1.2 Acquired Coagulation Factor Deficiency
  4. 5.2 Global 4 Factor Pro-thrombin Complex Concentrate Sales Volume by Application
  5. 5.2.1 Global 4 Factor Pro-thrombin Complex Concentrate Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global 4 Factor Pro-thrombin Complex Concentrate Sales Volume by Application (2021-2032)
  7. 5.2.3 Global 4 Factor Pro-thrombin Complex Concentrate Sales Volume Share by Application (2021-2032)
  8. 5.3 Global 4 Factor Pro-thrombin Complex Concentrate Sales Value by Application
  9. 5.3.1 Global 4 Factor Pro-thrombin Complex Concentrate Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global 4 Factor Pro-thrombin Complex Concentrate Sales Value by Application (2021-2032)
  11. 5.3.3 Global 4 Factor Pro-thrombin Complex Concentrate Sales Value Share by Application (2021-2032)
6 4 Factor Pro-thrombin Complex Concentrate Regional Sales and Value Analysis
  1. 6.1 Global 4 Factor Pro-thrombin Complex Concentrate Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global 4 Factor Pro-thrombin Complex Concentrate Sales by Region (2021-2032)
  3. 6.2.1 Global 4 Factor Pro-thrombin Complex Concentrate Sales by Region: 2021-2026
  4. 6.2.2 Global 4 Factor Pro-thrombin Complex Concentrate Sales by Region (2027-2032)
  5. 6.3 Global 4 Factor Pro-thrombin Complex Concentrate Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global 4 Factor Pro-thrombin Complex Concentrate Sales Value by Region (2021-2032)
  7. 6.4.1 Global 4 Factor Pro-thrombin Complex Concentrate Sales Value by Region: 2021-2026
  8. 6.4.2 Global 4 Factor Pro-thrombin Complex Concentrate Sales Value by Region (2027-2032)
  9. 6.5 Global 4 Factor Pro-thrombin Complex Concentrate Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America 4 Factor Pro-thrombin Complex Concentrate Sales Value (2021-2032)
  12. 6.6.2 North America 4 Factor Pro-thrombin Complex Concentrate Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe 4 Factor Pro-thrombin Complex Concentrate Sales Value (2021-2032)
  15. 6.7.2 Europe 4 Factor Pro-thrombin Complex Concentrate Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific 4 Factor Pro-thrombin Complex Concentrate Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific 4 Factor Pro-thrombin Complex Concentrate Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America 4 Factor Pro-thrombin Complex Concentrate Sales Value (2021-2032)
  21. 6.9.2 South America 4 Factor Pro-thrombin Complex Concentrate Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa 4 Factor Pro-thrombin Complex Concentrate Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa 4 Factor Pro-thrombin Complex Concentrate Sales Value Share by Country, 2025 VS 2032
7 4 Factor Pro-thrombin Complex Concentrate Country-level Sales and Value Analysis
  1. 7.1 Global 4 Factor Pro-thrombin Complex Concentrate Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global 4 Factor Pro-thrombin Complex Concentrate Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global 4 Factor Pro-thrombin Complex Concentrate Sales by Country (2021-2032)
  4. 7.3.1 Global 4 Factor Pro-thrombin Complex Concentrate Sales by Country (2021-2026)
  5. 7.3.2 Global 4 Factor Pro-thrombin Complex Concentrate Sales by Country (2027-2032)
  6. 7.4 Global 4 Factor Pro-thrombin Complex Concentrate Sales Value by Country (2021-2032)
  7. 7.4.1 Global 4 Factor Pro-thrombin Complex Concentrate Sales Value by Country (2021-2026)
  8. 7.4.2 Global 4 Factor Pro-thrombin Complex Concentrate Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA 4 Factor Pro-thrombin Complex Concentrate Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA 4 Factor Pro-thrombin Complex Concentrate Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA 4 Factor Pro-thrombin Complex Concentrate Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada 4 Factor Pro-thrombin Complex Concentrate Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada 4 Factor Pro-thrombin Complex Concentrate Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada 4 Factor Pro-thrombin Complex Concentrate Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico 4 Factor Pro-thrombin Complex Concentrate Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico 4 Factor Pro-thrombin Complex Concentrate Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico 4 Factor Pro-thrombin Complex Concentrate Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany 4 Factor Pro-thrombin Complex Concentrate Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany 4 Factor Pro-thrombin Complex Concentrate Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany 4 Factor Pro-thrombin Complex Concentrate Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France 4 Factor Pro-thrombin Complex Concentrate Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France 4 Factor Pro-thrombin Complex Concentrate Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France 4 Factor Pro-thrombin Complex Concentrate Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. 4 Factor Pro-thrombin Complex Concentrate Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. 4 Factor Pro-thrombin Complex Concentrate Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. 4 Factor Pro-thrombin Complex Concentrate Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy 4 Factor Pro-thrombin Complex Concentrate Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy 4 Factor Pro-thrombin Complex Concentrate Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy 4 Factor Pro-thrombin Complex Concentrate Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain 4 Factor Pro-thrombin Complex Concentrate Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain 4 Factor Pro-thrombin Complex Concentrate Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain 4 Factor Pro-thrombin Complex Concentrate Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia 4 Factor Pro-thrombin Complex Concentrate Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia 4 Factor Pro-thrombin Complex Concentrate Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia 4 Factor Pro-thrombin Complex Concentrate Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands 4 Factor Pro-thrombin Complex Concentrate Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands 4 Factor Pro-thrombin Complex Concentrate Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands 4 Factor Pro-thrombin Complex Concentrate Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries 4 Factor Pro-thrombin Complex Concentrate Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries 4 Factor Pro-thrombin Complex Concentrate Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries 4 Factor Pro-thrombin Complex Concentrate Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China 4 Factor Pro-thrombin Complex Concentrate Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China 4 Factor Pro-thrombin Complex Concentrate Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China 4 Factor Pro-thrombin Complex Concentrate Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan 4 Factor Pro-thrombin Complex Concentrate Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan 4 Factor Pro-thrombin Complex Concentrate Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan 4 Factor Pro-thrombin Complex Concentrate Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea 4 Factor Pro-thrombin Complex Concentrate Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea 4 Factor Pro-thrombin Complex Concentrate Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea 4 Factor Pro-thrombin Complex Concentrate Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India 4 Factor Pro-thrombin Complex Concentrate Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India 4 Factor Pro-thrombin Complex Concentrate Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India 4 Factor Pro-thrombin Complex Concentrate Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia 4 Factor Pro-thrombin Complex Concentrate Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia 4 Factor Pro-thrombin Complex Concentrate Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia 4 Factor Pro-thrombin Complex Concentrate Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia 4 Factor Pro-thrombin Complex Concentrate Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia 4 Factor Pro-thrombin Complex Concentrate Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia 4 Factor Pro-thrombin Complex Concentrate Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil 4 Factor Pro-thrombin Complex Concentrate Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil 4 Factor Pro-thrombin Complex Concentrate Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil 4 Factor Pro-thrombin Complex Concentrate Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina 4 Factor Pro-thrombin Complex Concentrate Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina 4 Factor Pro-thrombin Complex Concentrate Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina 4 Factor Pro-thrombin Complex Concentrate Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile 4 Factor Pro-thrombin Complex Concentrate Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile 4 Factor Pro-thrombin Complex Concentrate Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile 4 Factor Pro-thrombin Complex Concentrate Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia 4 Factor Pro-thrombin Complex Concentrate Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia 4 Factor Pro-thrombin Complex Concentrate Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia 4 Factor Pro-thrombin Complex Concentrate Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru 4 Factor Pro-thrombin Complex Concentrate Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru 4 Factor Pro-thrombin Complex Concentrate Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru 4 Factor Pro-thrombin Complex Concentrate Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia 4 Factor Pro-thrombin Complex Concentrate Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia 4 Factor Pro-thrombin Complex Concentrate Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia 4 Factor Pro-thrombin Complex Concentrate Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel 4 Factor Pro-thrombin Complex Concentrate Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel 4 Factor Pro-thrombin Complex Concentrate Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel 4 Factor Pro-thrombin Complex Concentrate Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE 4 Factor Pro-thrombin Complex Concentrate Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE 4 Factor Pro-thrombin Complex Concentrate Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE 4 Factor Pro-thrombin Complex Concentrate Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey 4 Factor Pro-thrombin Complex Concentrate Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey 4 Factor Pro-thrombin Complex Concentrate Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey 4 Factor Pro-thrombin Complex Concentrate Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran 4 Factor Pro-thrombin Complex Concentrate Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran 4 Factor Pro-thrombin Complex Concentrate Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran 4 Factor Pro-thrombin Complex Concentrate Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt 4 Factor Pro-thrombin Complex Concentrate Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt 4 Factor Pro-thrombin Complex Concentrate Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt 4 Factor Pro-thrombin Complex Concentrate Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Takeda
  2. 8.1.1 Takeda Company Information
  3. 8.1.2 Takeda Business Overview
  4. 8.1.3 Takeda 4 Factor Pro-thrombin Complex Concentrate Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Takeda 4 Factor Pro-thrombin Complex Concentrate Product Portfolio
  6. 8.1.5 Takeda Recent Developments
  7. 8.2 Prothya Biosolutions
  8. 8.2.1 Prothya Biosolutions Company Information
  9. 8.2.2 Prothya Biosolutions Business Overview
  10. 8.2.3 Prothya Biosolutions 4 Factor Pro-thrombin Complex Concentrate Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Prothya Biosolutions 4 Factor Pro-thrombin Complex Concentrate Product Portfolio
  12. 8.2.5 Prothya Biosolutions Recent Developments
  13. 8.3 Octapharma
  14. 8.3.1 Octapharma Company Information
  15. 8.3.2 Octapharma Business Overview
  16. 8.3.3 Octapharma 4 Factor Pro-thrombin Complex Concentrate Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Octapharma 4 Factor Pro-thrombin Complex Concentrate Product Portfolio
  18. 8.3.5 Octapharma Recent Developments
  19. 8.4 CSL Behring
  20. 8.4.1 CSL Behring Company Information
  21. 8.4.2 CSL Behring Business Overview
  22. 8.4.3 CSL Behring 4 Factor Pro-thrombin Complex Concentrate Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 CSL Behring 4 Factor Pro-thrombin Complex Concentrate Product Portfolio
  24. 8.4.5 CSL Behring Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 4 Factor Pro-thrombin Complex Concentrate Value Chain Analysis
  2. 9.1.1 4 Factor Pro-thrombin Complex Concentrate Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 4 Factor Pro-thrombin Complex Concentrate Sales Mode & Process
  6. 9.2 4 Factor Pro-thrombin Complex Concentrate Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 4 Factor Pro-thrombin Complex Concentrate Distributors
  9. 9.2.3 4 Factor Pro-thrombin Complex Concentrate Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst